JPMorgan Chase & Co’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-53,522
| Closed | -$14K | – | 6455 |
|
|
2023
Q1 | $14K | Buy |
53,522
+14,507
| +37% | +$3.8K | ﹤0.01% | 5219 |
|
|
2022
Q4 | $46K | Buy |
39,015
+1,865
| +5% | +$2.2K | ﹤0.01% | 4769 |
|
|
2022
Q3 | $76K | Sell |
37,150
-54,819
| -60% | -$112K | ﹤0.01% | 4574 |
|
|
2022
Q2 | $142K | Buy |
91,969
+90,569
| +6,469% | +$140K | ﹤0.01% | 4475 |
|
|
2022
Q1 | $7K | Buy |
+1,400
| New | +$7K | ﹤0.01% | 5459 |
|
|
2021
Q4 | – | Sell |
-92,831
| Closed | -$923K | – | 6047 |
|
|
2021
Q3 | $923K | Buy |
+92,831
| New | +$923K | ﹤0.01% | 3661 |
|